A dominant-negative cyclin D1 mutant prevents nuclear import of cyclin- dependent kinase 4 (CDK4) and its phosphorylation by CDK-activating kinase

Molecular and Cellular Biology

Volumn 17, Issue 12, 1997, Pages 7362-7374

  Diehl, J Alan ^a   Sherr, Charles J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE CAK; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOPLASM; ENZYME PHOSPHORYLATION; MITOSIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT;

ANIMALIA; MAMMALIA;

EID: 0030657477     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.12.7362     Document Type: Article

References (107)

1. Andersen, G., D. Busso, A. Poterszman, J. R. Hwang, J.-M. Wurtz, R. Ripp, J.-C. Thierry, J.-M. Egly, and D. Moras. 1997. The structure of cyclin H: common mode of kinase activation and specific features. EMBO J. 16:958-967.
2. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
3. Boyle, W. J., P. Van der Geer, and T. Hunter. 1991. Protein phosphorylation. B. Analysis of protein phosphorylation, protein kinase inhibitors, and protein phosphotases. Methods Enzymol. 201:21-27.
4. Bram, R. J., and G. R. Crabtree. 1994. Calcium signaling in T cells stimulated by a cyclophilin B-binding protein. Nature 371:355-358.
5. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557.
6. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
7. Cismowski, M. J., G. M. Laff, M. J. Solomon, and S. I. Reed. 1995. KIN28 encodes a C-terminal domain kinase that controls mRNA transcription in Saccharomyces cerevisiae but lacks cyclin-dependent kinase-activating kinase activity. Mol. Cell. Biol. 15:2983-2992.
8. Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287-301.
9. DeBondt, H. L., J. Rosenblatt, J. Jancarik, H. D. Jones, D. O. Morgan, and S. Kim. 1993. Crystal structure of cyclin-dependent kinase 2. Nature 363: 595-602.
10. Cip1/Waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
11. Desai, D., H. C. Wessling, R. P. Fisher, and D. O. Morgan. 1995. Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol. Cell. Biol. 15:345-350.
12. Devault, A., A. M. Martinez, D. Fesquet, J. C. Labbe, N. Morin, J. P. Tassan, E. A. Nigg, J. C. Cavadore, and M. Doree. 1995. MAT1 ('menage a trois') a new RING finger protein subunit stabilizing cyclin H-cdk7 complexes in starfish and Xenopus CAK. EMBO J. 14:5027-5036.
13. Diehl, J. A., F. Zindy, and C. J. Sherr. 1997. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev. 11:957-972.
14. Downing, J. R., C. W. Rettenmier, and C. J. Sherr. 1988. Ligand-induced tyrosine kinase activity of the colony stimulating factor 1 receptor in a murine macrophage cell line. Mol. Cell. Biol. 8:1795-1799.
15. Ducommun, B., P. Brambilla, M. Felix, B. R. Franza, Jr., E. Karsenti, and G. Draetta. 1991. cdc2 phosphorylation is required for its interaction with cyclin. EMBO J. 10:3311-3319.
16. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023.
17. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
18. Elledge, S. J., and J. W. Harper. 1994. CDK inhibitors: on the threshold of check points and development. Curr. Opin. Cell Biol. 6:847-852.
19. Espinoza, F. H., A. Farrell, H. Erdjument-Bromage, P. Tempst, and D. O. Morgan. 1996. A cyclin-dependent kinase-activating kinase (CAK) in budding yeast unrelated to vertebrate CAK. Science 273:1714-1717.
20. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
21. Feaver, W. J., J. Q. Svejstrup, N. L. Henry, and R. D. Kornberg. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79:1103-1109.
22. Filmus, J., A. I. Robles, W. Shi, M. J. Wong, L. L. Colombo, and C. J. Conti. 1994. Induction of cyclin D1 overexpression by activated ras. Oncogene 9:3627-3633.
23. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14:4889-4901.
24. Fisher, R. P., P. Jin, H. M. Chamberlin, and D. O. Morgan. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47-57.
25. Fisher, R. P., and D. O. Morgan. 1994. A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase. Cell 78:713-724.
26. Girard, F., U. Strausfeld, A. Fernandez, and N. J. C. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179.
27. Gu, Y., C. W. Turek, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
28. INK4B/MTS2-related cdk6, inhibitor, correlates with wild-type pRb function. Genes Dev. 8:2939-2952.
29. Hall, M., and G. Peters. 1996. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer. Adv. Cancer Res. 68:67-108.
30. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
31. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
32. Hatakeyama, M., J. A. Brill, G. R. Fink, and R. A. Weinberg. 1994. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8:1759-1771.
33. Higashi, H., I. Suzuki-Takahashi, S. Saitoh, K. Segawa, Y. Taya, A. Okuyama, S. Nishimura, and M. Kitagawa. 1996. Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H. Eur. J. Biochem. 237:460-467.
34. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
35. Hirai, H., M. F. Roussel, J. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
36. Iavarone, A., and J. Massague. 1997. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature 387:417-422.
37. Inaba, T., T. Inukai, T. Yoshihara, H. Seyschab, R. A. Ashmun, C. E. Canman, S. J. Laken, M. B. Kastan, and A. T. Look. 1996. Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382:541-544.
38. Jeffrey, P. D., A. A. Russo, K. Polyak, E. Gibbs, J. Hurwitz, J. Massague, and N. P. Pavletich. 1995. Mechanism of CDK activation revealed by the structure of a cyclin A-CDK2 complex. Nature 376:313-320.
39. Jiang, W., S. M. Kahn, P. Zhou, Y. Zhang, A. M. Cacace, A. S. Infante, S. Doi, R. M. Santella, and I. B. Weinstein. 1993. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression, and gene expression. Oncogene 8:3447-3457.
40. Kaldis, P., A. Sutton, and M. J. Solomon. 1996. The Cdk-activating kinase (CAK) from budding yeast. Cell 86:553-564.
41. Kip1) of cyclin-dependent kinase-4 activation. Cell 79:487-496.
42. Kato, J., M. Matsuoka, D. K. Strom, and C. J. Sherr. 1994. Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase. Mol. Cell. Biol. 14:2713-2721.
43. Kim, K. K., H. M. Chamberlin, D. O. Morgan, and S. H. Kim. 1996. Three-dimensional structure of human cyclin H, a positive regulator of the CDK-activating kinase. Nat. Struct. Biol. 3:849-855.
44. Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumour-derived p16 alleles encoding proteins defective in cell cycle inhibition. Nature 375:506-510.
45. Krek, W., M. E. Ewen, S. Shirodkar, Z. Arany, W. G. Kaelin, and D. M. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78:161-171.
46. Krek, W., G. Xu, and D. M. Livingston. 1995. Cyclin A kinase regulation of E2F-1DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158.
47. Krude, T., M. Jackman, J. Pines, and R. A. Laskey. 1997. Cyclin/cdk-dependent initiation of DNA replication in a human cell-free system. Cell 88:109-119.
48. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
49. Li, J., A. N. Meyer, and D. J. Donoghue. 1997. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. Proc. Natl. Acad. Sci. USA 94:502-507.
50. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
51. 1 progression in NIH 3T3 cells. Mol. Cell. Biol. 15:3654-3663.
52. Lovec, H., A. Sewing, F. C. Lucibello, R. Muller, and T. Moroy. 1994. Oncogene activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323-326.
53. Lukas, J., H. Muller, J. Bartkova, D. Spitkovsky, A. A. Kjerulff, P. Jansen-Durr, M. Strauss, and J. Bartek. 1994. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125:625-638.
54. 1 control in retinoblastoma gene-deficient cells, independent of CDK4 activity. Mol. Cell. Biol. 15:2600-2611.
55. Lukas, J., T. Herzinger, K. Hansen, M. C. Moroni, D. Resnitzky, K. Helin, S. I. Reed, and J. Bartek. 1997. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev. 11:1479-1492.
56. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartkova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature 375:503-506.
57. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9:935-944.
58. Makela, T. P., J. P. Tassan, E. A. Nigg, S. Frutiger, G. J. Hughes, and R. A. Weinberg. 1994. A cyclin associated with the cdk-activating kinase MO15. Nature 371:254-257.
59. Mantel, C., Z. Luo, J. Canfield, S. Braun, C. Deng, and H. E. Broxmeyer. 1996. Involvement of p21Cip1 and p27Kip1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21Cip1 in the maintenance of stem/progenitor cells in vivo. Blood 88:3710-3719.
60. Matsuoka, M., J. Kato, R. P. Fisher, D. O. Morgan, and C. J. Sherr. 1994. Activation of cyclin-dependent kinase 4 by mouse MO15-associated kinase. Mol. Cell. Biol. 14:7265-7275.
61. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
62. Matsushime, H., M. F. Roussel, R. A. Ashmun, and C. J. Sherr. 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713.
63. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289-6293.
64. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
65. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Inhibition of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54:3391-3395.
66. Morgan, D. O. 1995. Principles of cdk regulation. Nature 374:131-134.
67. Morgan, D. O. 1996. Under arrest at atomic resolution. Nature 382:295-296.
68. Nigg, E. A. 1991. The substrates of the cdc2 kinase. Semin. Cell Biol. 2:261-270.
69. Noda, A., Y. Ning, S. F. Venable, O. M. Pereira-Smith, and J. R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
70. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
71. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
72. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961-971.
73. Pagano, M., A. M. Theodoras, S. W. Tam, and G. F. Draetta. 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8:1627-1639.
74. Pines, J., and T. Hunter. 1991. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol. 115:1-17.
75. Pines, J., and T. Hunter. 1994. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B. EMBO J. 13:3772-3781.
76. cdc2. EMBO J. 12:3123-3132.
77. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
78. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
79. Rettenmier, C. W., J. H. Chen, M. F. Roussel, and C. J. Sherr. 1985. The product of the c-fms proto-oncogene: a glycoprotein with associated tyrosine kinase activity. Science 228:320-322.
80. Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J.-P. Tassan, L. Schaeffer, E. A. Nigg, J. H. J. Hoeijmakers, and J.-M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093-1101.
81. Russo, A. A., P. D. Jeffrey, A. K. Patten, J. Massagué, and N. P. Pavletich. 1996. Crystal structure of the p27Kipl cyclin-dependent kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382:325-331.
82. Russo, A. A., P. D. Jeffrey, and N. P. Pavletich. 1996. Structural basis of cyclin-dependent kinase activation by phosphorylation. Nat. Struct. Biol. 3:696-700.
83. Serizawa, H., T. P. Makela, J. W. Conaway, R. C. Conaway, R. A. Weinberg, and R. A. Young. 1995. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 374:280-282.
84. INK4. Science 267:249-252.
85. Sheaff, R., M. Groudine, M. Gordon, J. Roberts, and B. Clurman. 1997. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 11:1464-1478.
86. Sheikh, M. D., X. Li, J. Chen, Z. Shao, J. V. Ordonez, and J. A, Fontana. 1994. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3415.
87. 1 cyclins. Cell 73:1059-1065.
88. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
89. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
90. Shiekhattar, R., F. Mermelstein, R. P. Fisher, R. Drapkin, B. Dynlacht, H. C. Wessling, D. O. Morgan, and D. Reinberg. 1995. Cdk-activating kinase complex is a component of human transcription factor TFIIH. Nature 374:283-287.
91. MO15. EMBO J. 12:3133-3142.
92. cdc2 activation: identification of an activating kinase. Mol. Biol. Cell 3:13-27.
93. Summers, M. D., and G. E. Smith. 1987. A manual of methods for baculovirus vectors and insect culture procedures. Texas Agricultural Experimental Station Bulletin no. 1555. Texas Agricultural Experimental Station, College Station, Tex.
94. Tassan, J. P., S. J. Schultz, J. Bartek, and E. A. Nigg. 1994. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127:467-478.
95. Terada, Y., M. Tatsuka, S. Jinno, and H. Okayama. 1995. Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376:358-362.
96. Thuret, J. Y., J. G. Valay, G. Faye, and C. Mann. 1996. Civ1 (CAK in vivo), a novel Cdk-activating kinase. Cell 86:565-576.
97. Uchimaru, K., K. Endo, H. Fujinuma, L. Zukerberg, A. Arnold, and T. Motokura. 1996. Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation. Jpn. J. Cancer Res. 87:459-465.
98. Vallance, S. J., H. Lee, M. F. Roussel, S. A. Shurtleff, J. Kato, D. K. Strom, and C. J. Sherr. 1993. Monoclonal antibodies to mammalian D-type G1 cyclins. Hybridoma 13:37-44.
99. Walker, D. H., and J. L. Maller. 1991. Role for cyclin A in the dependence of mitosis on completion of DNA replication. Nature 354:314-317.
100. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
101. Winston, J. T., S. R. Coats, Y.-Z. Wang, and W. J. Pledger. 1996. Regulation of the cell cycle machinery by oncogenic ras. Oncogene 12:127-134.
102. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
103. Xiong, Y., H. Zhang, and D. Beach. 1992. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
104. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.
105. Zhang, H., G. J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8:1750-1758.
106. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897-906.
107. Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fesquet, B. Henglein, and C. Brechot. 1992. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182:1144-1154.